Johnson & Johnson JNJ
NYSE JNJ
$267.21 -1.91 (-0.71%)
As of: Sep 9, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Interest Expenses (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Interest Expenses came in at $281.0 million in Q2 2026, down 8.77% year-over-year from $308.0 million in Q2 2025, and up 3.31% quarter-over-quarter from $272.0 million in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Interest Expenses (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Interest Expenses across 18 years of filings, most recently posting $281.0 million for Q2 2026.

  • In Q2 2026, Interest Expenses fell 8.77% year-over-year to $281.0 million; the TTM figure through Jun 2026 stood at $1.0 billion (up 20.19% YoY), while the FY2025 annual figure was $971.0 million, up 28.61% from the prior year.
  • Interest Expenses came in at $281.0 million for Q2 2026 at Johnson & Johnson, up from $272.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $308.0 million in Q2 2025 to a low of $10.0 million in Q2 2022.
  • Average Interest Expenses over 5 years is $183.5 million, with a median of $198.5 million recorded in 2024.
  • Year-over-year, Interest Expenses tumbled 84.13% in 2022 and surged 2020.0% in 2023.
  • Over 5 years, Interest Expenses stood at $51.0 million in 2022, then surged by 196.08% to $151.0 million in 2023, then dropped by 9.27% to $137.0 million in 2024, then surged by 56.2% to $214.0 million in 2025, then surged by 31.31% to $281.0 million in 2026.
  • Per Business Quant data, the three most recent Interest Expenses figures were $281.0 million in Q2 2026, $272.0 million in Q1 2026, and $214.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 281.00 Mn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -462.00 Mn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -333.60 Mn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 23.78 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 582,000.00
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 2.90 Mn
10 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn 2.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 281.00 Mn
Mar 29, 2026 272.00 Mn
Dec 28, 2025 214.00 Mn
Sep 28, 2025 245.00 Mn
Jun 29, 2025 308.00 Mn
Mar 30, 2025 204.00 Mn
Dec 29, 2024 137.00 Mn
Sep 29, 2024 193.00 Mn
Jun 30, 2024 270.00 Mn
Mar 31, 2024 155.00 Mn
Dec 31, 2023 151.00 Mn
Oct 1, 2023 192.00 Mn
Jul 2, 2023 217.00 Mn
Apr 2, 2023 212.00 Mn
Jan 1, 2023 153.00 Mn
Oct 2, 2022 51.00 Mn
Jul 3, 2022 38.00 Mn
Apr 3, 2022 10.00 Mn
Oct 3, 2021 20.00 Mn
Jul 4, 2021 40.00 Mn